$25.14
-0.75-2.9%
Last update: Oct 15, 2:43 PM
Parabilis Medicines Inc
PBLSNASDAQ
Market sentiment signals for Parabilis Medicines (PBLS): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
3 analysts
Options Flow (P/C)
—
Avg Consensus PT
$42
+65.8%
Highest Price Target
$45
+79.0%
Lowest Price Target
$40
+59.1%
Short Interest
6.8%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Leerink Partners | Andrew Berens— | +59.1% | $40 | Initiate | Outperform |
| Jul 6, 2026 | Guggenheim | Michael Schmidt— | +59.1% | $40 | Initiate | Buy |
